Esquizofrenia
Publicaciones destacadas
-
Early treatment with JNJ-46356479, a mGluR2 modulator, improves behavioral and neuropathological deficits in a postnatal ketamine mouse model of schizophrenia
Martinez-Pinteno, A; Rodriguez, N; Olivares, D; Madero, S; Gomez, M;(...)Garcia-Rizo, C; Mas, S; Moren, C; Parellada, E; Gasso, P.Referencia:Biomedicine & Pharmacotherapy 2023.
-
Deep brain stimulation and digital monitoring for patients with treatment-resistant schizophrenia and bipolar disorder: A case series
Bioque M; Rumià J; Roldán P; Hidalgo-Mazzei D; Montejo L;Benabarre A; Gil-Badenes J; Tercero J; Parellada E; Vieta E.Referencia:Revista De Psiquiatria Y Salud Mental 2023.
-
Dried Blood Spot (DBS) as a useful tool to improve clozapine, aripiprazole and paliperidone treatment: From adherence to efficiency
Bernardo, M; Mezquida, G; Ferré, P; Cabrera, B; Torra, M;Lizana, AM; Brunet, M.Referencia:Revista De Psiquiatria Y Salud Mental 2022.
-
Mapping Retinal Abnormalities in Psychosis: Meta-analytical Evidence for Focal Peripapillary and Macular Reductions
Gonzalez-Diaz, Jairo M; Radua, Joaquim; Sanchez-Dalmau, Bernardo; Camos-Carreras, Anna; Zamora, Diana C;Bernardo, Miquel.Referencia:Schizophrenia Bulletin 2022.
-
Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort.
Mas, S; Gasso, P; Rodriguez, N; Cabrera, B; Mezquida, G;(...)Butjosa, Anna; Pardo, Marta; Pomarol-Clotet, Edith; Ibanez Cuadrado, Angela; Cuesta, Manuel J.Referencia:Acta Psychiatrica Scandinavica 2020.
-
Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study
Garcia-Rizo, Clemente; Bioque, Miquel; Mezquida, Gisela; Amoretti, Silvia; Cuesta, Manuel J;(...)Sarro, Salvador; Pomarol-Clotet, Edith; Ibanez, Angela; Sanchez-Torres, Ana M; Selva-Vera, Gabriel.Referencia:Schizophrenia Research 2020.
-
CLOZAPINE AND PALIPERIDONE PALMITATE ANTIPSYCHOTIC COMBINATION IN TREATMENT-RESISTANT SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS: A RETROSPECTIVE 6-MONTH MIRROR-IMAGE STUDY
Bioque, Miquel; Parellada, Eduard; Garcia-Rizo, Clemente; Amoretti, Silvia; Fortea, Adriana;Oriolo, Giovanni; Palau, Pol; Boix-Quintana, Ester; Safont, Gemma; Bernardo, Miquel.Referencia:European Psychiatry 2020.
-
One decade of the first episodes project (PEPs): Advancing towards a precision psychiatry
Bernardo, M; Cabrera, B; Arango, C; Bioque, M; Castro-Fornieles, J;Cuesta, MJ; Lafuente, A; Parellada, M; Saiz-Ruiz, J; Vieta, E.Referencia:Revista De Psiquiatria Y Salud Mental 2019.
-
A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments
Arranz, Maria J.; Gonzalez-Rodriguez, Alex; Perez-Blanco, Josefina; Penades, Rafael; Gutierrez, Blanca;(...)Arias, Barbara; Brunet, Merce; Cervilla, Jorge; Salazar, Juliana; Catalan, Rosa;.Referencia:Translational Psychiatry 2019.
-
BDNF as a marker of response to cognitive remediation in patients with schizophrenia: A randomized and controlled trial
Penades, Rafael; Lopez-Vilchez, Irene; Catalan, Rosa; Arias, Barbara; Gonzalez-Rodriguez, Alexandre;Garcia-Rizo, Clemente; Masana, Guillem; Ruiz, Victoria; Mezquida, Gisela; Bernardo, Miquel.Referencia:Schizophrenia Research 2018.